Navigation Links
Masimo Reports Third Quarter 2009 Financial Results
Date:11/3/2009

asure many blood constituents that previously required invasive procedures. Rainbow SET continuously and noninvasively measures total hemoglobin (SpHb(TM)), oxygen content (SpOC(TM)), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and PVI®, in addition to oxyhemoglobin (SpO2), pulse rate (PR), and perfusion index (PI), allowing early detection and treatment of potentially life-threatening conditions. Founded in 1989, Masimo has the mission of "Improving Patient Outcomes and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications." Additional information about Masimo and its products may be found at www.masimo.com. Information on the company's website does not form part of this press release.

Forward-Looking Statements

All statements other than statements of historical facts included in this press release that address activities, events or developments that we expect, believe or anticipate will or may occur in the future are forward-looking statements including, in particular, the statements about: our financial condition, results of operations, prospects and business generally; and expectations regarding our ability to design and deliver innovative new noninvasive technologies. These forward-looking statements are based on management's current expectations and beliefs and are subject to uncertainties and factors, all of which are difficult to predict and many of which are beyond our control and could cause actual results to differ materially and adversely from those described in the forward-looking statements. These risks include, but are not limited to, those related to: our dependence on Masimo SET and Masimo Rainbow SET products and technologies for substantially all of our revenue; any failure in protecting our intellectual property exposure to competitors' assertions of intellectual property claims; the highly competitive nature of the marke
'/>"/>

SOURCE Masimo Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. The MED Group Signs Preferred Supplier Agreement for Masimo SET(R) Pulse Oximetry Solutions
2. University Medical Center Mainz Completes Installation of Masimo Noninvasive and Continuous Hemoglobin Throughout Their Operating Rooms, Intensive Care Units and Emergency Department
3. FDNY Makes Largest First Responder Purchase of Masimo Rad-57 Pulse CO-Oximeters to Improve Survival of Firefighters and Victims of Carbon Monoxide Poisoning
4. Childrens Hospital Los Angeles Completes Conversion to Masimo SET(R) Pulse Oximetry Technology
5. IRadimed Announces 510K Clearance of the New Non-Magnetic MRidium(TM) MRI IV Pump with Integrated Masimo SET(R) SpO2 Monitoring
6. Masimo and the International Association of Fire Chiefs Launch Nationwide Health & Safety Program to Reduce Firefighter Death and Injury
7. Masimo and Oridion Sign Connectivity Agreement to Integrate Capnostream(TM)20 Portable Bedside Monitors into the Masimo Patient SafetyNet(TM) System
8. The International Association of Fire Fighters and Masimo Team Up on a New Global Campaign to Raise Awareness of Carbon Monoxide-Related Death and Injury Risks for Fire Fighters
9. Masimo to Report Second Quarter 2009 Financial Results on August 4, 2009
10. Masimo Receives FDA Clearance for New Rainbow(R) Resposable(TM) Sensor System
11. Masimo Announces Settlement of Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... that certain businesses with large areas where people gather, need ... Fire and rescue personnel agree that for any size business, ... , ... Issaquah, WA (PRWEB) December 15, ... certain businesses with large areas where people gather, need to ...
(Date:12/15/2009)... Dec. 15 "The entire San Diego Hospice ... passing of Sol Price on December 14, 2009. Mr. ... integrity, loyalty and ethics in his business, community and ... humanitarian who truly understood the responsibility of philanthropy and ... legacy will live on through his countless philanthropic efforts. ...
(Date:12/15/2009)... Southwestern Medical Center researchers have provided the most ... characteristics seen in patients with an extremely rare ... and in the December issue of the ... that patients with atypical progeroid syndrome (APS) should ... two similar but more well-defined accelerated aging disorders ...
(Date:12/14/2009)... carry oxygen, drugs, and more… , ... ... Barbara, in collaboration with scientists at University of Michigan, have ... functions of natural red blood cells, including softness, flexibility, and ... ,The primary function of natural red blood cells is to ...
(Date:12/14/2009)... PARK, Ill. and HOLLYWOOD, Fla., Dec. 14 ... ) announced today a definitive agreement to ... ), a leading provider of laboratory information ... cash. ,, The acquisition strengthens Abbott,s ... providing advanced web-based applications to help laboratories ...
Breaking Medicine News(10 mins):Health News:QuickMedical Responds to Oregon Bill Requiring Businesses to Carry Defibrillators 2Health News:QuickMedical Responds to Oregon Bill Requiring Businesses to Carry Defibrillators 3Health News:San Diego Hospice and The Institute for Palliative Medicine on the Passing of Sol Price 2Health News:Researchers ID traits of people with rare accelerated aging syndrome 2Health News:Synthetic Red Blood Cells Developed 2Health News:Synthetic Red Blood Cells Developed 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4
... term a single drug may be used to treat both ... is a psychotic disorder characterized by successive feelings of elation ... to 4 5 of the global adult population. This is ... occurrences of the condition for most of their lives. ...
... human body can release chemical compounds like marijuana that can ... of pain from severe trauma // like accidents. ... gun shot, or accidents causing severe damage to body, delays ... as stress-induced analgesia, or body’s reaction to shield the severe ...
... substantia nigra ,an area in the basal ganglia. The disease ... by the British physician Dr. James Parkinson and the associated ... the 1960s. Although some genes were identified only recently, others ... recently it was seen that a drug previously used to ...
... teenager may minimize your risks of developing dementia and memory ... done by the scientists of the University Memory and Aging ... that teenage intelligent quotient (IQ) may be related to how ... his old age. ,Dementia is a condition where ...
... period of gestation has a profound effect on the psychological ... children even if born full term but weighing below ... their adulthood. This being the same after taking into consideration ... maternal age. Until recently it has been unclear whether the ...
... conducted by International Agency for Research on Cancer (IARC) in ... workers who are exposed to chronic low doses of radiation ... the largest study ever conducted in 15 countries involving 407,000 ... could lead to a 10 percent raised risk of death ...
Other Medicine News:Health News:Re –growing Brain cells destroyed by Parkinson’s disease 2Health News:Is low birth weight related to psychological distress in adulthood? 2
(Date:12/14/2009)... Calif., Dec. 14 The Roberts ... today released the analysis of social responsibility ... world-wide. The report contains a compilation of ... environmental and social reporting of the companies. ... and performance for both environmental and social ...
(Date:12/14/2009)... According to Millennium Research Group ... market intelligence, Japan,s complex regulatory environment and ... significant lag in peripheral vascular stenting device ... developed nations. MRG,s new Japanese ... report finds, however, that recent indication-specific device ...
(Date:12/14/2009)... The U.S. Food and Drug Administration (FDA) ... Suspension for the treatment of schizophrenia in adults, ... ) announced today. ZYPREXA RELPREVV, a long-acting intramuscular ... to four weeks. ,, Different from both oral ... allow for stable concentrations of the active drug ...
Breaking Medicine Technology:New Report Grades Sustainability Reporting of Top Pharmaceutical Companies 2New Report Grades Sustainability Reporting of Top Pharmaceutical Companies 3Japanese Peripheral Vascular Stent Procedures to Experience 11% Growth Through 2014 2Japanese Peripheral Vascular Stent Procedures to Experience 11% Growth Through 2014 3FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 2FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 3FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 4FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 5FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 6FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 7FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 8FamilyLife Supports Military Marriages in Atlanta 62459 1FamilyLife Supports Military Marriages in Atlanta 62459 2Ministerial Roundtable Discusses Future of Medical Tourism 62455 1Ministerial Roundtable Discusses Future of Medical Tourism 62455 2Ministerial Roundtable Discusses Future of Medical Tourism 62455 3Peregrine Completes Patient Enrollment in Cotara 28R 29 Dose Confirmation and Dosimetry Brain Cancer Trial 15048 1Peregrine Completes Patient Enrollment in Cotara 28R 29 Dose Confirmation and Dosimetry Brain Cancer Trial 15048 2Peregrine Completes Patient Enrollment in Cotara 28R 29 Dose Confirmation and Dosimetry Brain Cancer Trial 15048 3Peregrine Completes Patient Enrollment in Cotara 28R 29 Dose Confirmation and Dosimetry Brain Cancer Trial 15048 4Peregrine Completes Patient Enrollment in Cotara 28R 29 Dose Confirmation and Dosimetry Brain Cancer Trial 15048 5
... England, December 8 , ... Completed Price and,Reimbursement Approval for Tetrabenazine in H1 2009 ... Distribution Rights Granted in Finland (MediFront) and Taiwan,(Giddi Pharma); ... Cambridge Laboratories Limited ...
... 7 Millennium: The Takeda Oncology,Company today ... randomized, multi-center,Company-sponsored Phase I/II study of VELCADE, ... previously untreated multiple,myeloma (MM). The preliminary analysis ... of four drugs was generally well tolerated ...
Other Medicine Technology:Cambridge Laboratories Announces Approval of Tetrabenazine in Spain 2Cambridge Laboratories Announces Approval of Tetrabenazine in Spain 3Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 2Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 3Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 4Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 5Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 6
Used to introduce balloon, diagnostic and guiding catheters, or other devices for intervention....
Used to introduce balloon, closed and non-tapered end catheters or other devices for intervention....
Used to introduce balloon, diagnostic and guiding catheters, or other devices for intervention....
Used to introduce large devices for vascular intervention....
Medicine Products: